Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness, in a Multi-Center, Randomized, Sham Controlled Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD)Using Rheopheresis

NCT00460967 is registered in ClinicalTrials.gov with OccuLogix as lead sponsor.

NCT NCT00460967
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00460967 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness, in a Multi-Center, Randomized, Sham Controlled Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD)Using Rheopheresis
Lead sponsor
OccuLogix
Phase
Phase 3
Overall status
Suspended
Start date
January 31, 2007
Completion date
December 31, 2009
Enrollment
325 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

age-related maculopathy